PMS2 Improvements in Physical Function and Disability in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A Trial
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1357
https://www.valueinhealthjournal.com/article/S1098-3015(12)03070-7/fulltext
Title :
PMS2 Improvements in Physical Function and Disability in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03070-7&doi=10.1016/j.jval.2012.08.1357
First page :
A439
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
854